Prognostic Differences of Refractory/relapsed Nodal and Extranodal Diffuse Large B-cell Lymphoma in the Chimeric Antigen Receptor T Cell Therapy Era.
Clinica Chimica Acta（2022）
关键词
Refractory,relapsed nodal diffuse large B-cell,lymphoma,relapsed extranodal diffuse large B-,cell lymphoma,CD19 chimeric antigen receptor T cell therapy,Autologous hematopoietic stem cell,transplantation,Prognosis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要